Safinamide mesylate 202825-46-5
TDS
202825-46-5
Pharmaceutical Grade
99%
Zison
foil bag
2023-02-28
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Safinamide mesylate
Other Name:Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(2S)-,methanesulfonate (1:1);Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(S)-,monomethanesulfonate;Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(2S)-,monomethanesulfonate;PNU 151774E;NW 1015;Safinamide mesylate;(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide methanesulfonate;Safinamide methanesulfonate;EMD 1195686 mesylate;Xadago
CAS No.:202825-46-5
Molecular Formula:C17H19FN2O2.CH4O3S
InChIKeys:InChIKey=YKOCHIUQOBQIAC-YDALLXLXSA-N
Molecular Weight:398.4490232
Exact Mass:398.131165
EC Number:606-485-0
HScode:2924299090
Categories:
Characteristics-
PSA:
127
XLogP3:4.04410
Appearance:white to tan
Melting Point:210° (dec)
Boiling Point:476.7ºC at 760 mmHg
Flash Point:242.1ºC
Water Solubility:H2O: ≥15mg/mL
Storage Conditions:2-8°C
Specific rotation:D25 +12.9° (c = 1.1% in 98% acetic acid)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 3, Oral
Serious eye damage, Category 1
Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H301 Toxic if swallowed
H318 Causes serious eye damage
H400 Very toxic to aquatic life
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P273 Avoid release to the environment.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P317 Get medical help.
P391 Collect spillage.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Location:
Room 410, Building 9, No. 2566, Century Avenue, Jinan, 250104, China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2021
-
Certifications:
business license,ISO
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
